Mereo BioPharma Group plc·4

Sep 13, 4:57 PM ET

Sermon Charles 4

4 · Mereo BioPharma Group plc · Filed Sep 13, 2024

Insider Transaction Report

Form 4
Period: 2024-09-11
Sermon Charles
General Counsel
Transactions
  • Exercise/Conversion

    Performance Based Restricted Stock Unit

    2024-09-1165,6000 total
    Exercise: $0.00From: 2024-09-11Exp: 2025-01-25American Depository Shares (65,600 underlying)
  • Exercise/Conversion

    American Depositary Shares representing Ordinary Shares

    2024-09-11+65,600249,987 total
Footnotes (3)
  • [F1]Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.
  • [F2]Represents performance-based restricted stock unit earned under the Issuer's 2019 Employee Incentive Plan (the "Plan"), that vested on September 11, 2024 based on satisfaction of ADS price threshold values over a two year performance period.
  • [F3]Reporting Person also beneficially owns 4 ordinary shares, nominal value of GBP 0.003 per ordinary share, of the Issuer.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4